{"id":327052,"date":"2026-10-26T16:50:02","date_gmt":"2026-10-26T11:20:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=327052"},"modified":"2026-10-26T16:50:02","modified_gmt":"2026-10-26T11:20:02","slug":"chronic-therapy-brands-company-domestic-acute-care-leader-and-active-ingredients-producer-stocks-roadmap-summit-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/chronic-therapy-brands-company-domestic-acute-care-leader-and-active-ingredients-producer-stocks-roadmap-summit-list\/","title":{"rendered":"3 Chronic Therapy Brands Company, Domestic Acute Care Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Eris Lifesciences, Alkem Laboratories and Granules India"},"content":{"rendered":"

Eris Lifesciences, Alkem Laboratories and Granules India: ROE of 11.7% to 16.7% and FY22 to FY26 revenue CAGR of 9.1% to 22.9%. Prices as of 23 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three chronic, acute care and ingredient pharma stocks to watch are Eris Lifesciences, Alkem Laboratories and Granules India. Their return on equity ranges from 11.7% to 16.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.1% to 22.9%. Alkem Laboratories has the highest return on equity at 16.7%, while Eris Lifesciences has the fastest revenue growth at 22.9% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Chronic, acute care and ingredient pharma stocks let investors follow companies that serve a growing part of the Indian economy. Eris Lifesciences, Alkem Laboratories and Granules India cover a chronic therapy brands company, a domestic acute care leader and an active ingredients producer.<\/p>\n

This list covers three chronic, acute care and ingredient pharma stocks with complete current figures: Eris Lifesciences, Alkem Laboratories and Granules India. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n